You are currently on the new version of our website. Access the old version .

647 Results Found

  • Review
  • Open Access
38 Citations
39,821 Views
27 Pages

The SARS-CoV-2 (severe acute respiratory syndrome coronavirus responsible for the COVID-19 disease) uses the Spike proteins of its envelope for infecting target cells expressing on the membrane the angiotensin converting enzyme 2 (ACE2) enzyme that a...

  • Review
  • Open Access
54 Citations
9,405 Views
45 Pages

Nanobiosensors for the Detection of Novel Coronavirus 2019-nCoV and Other Pandemic/Epidemic Respiratory Viruses: A Review

  • Badriyah Alhalaili,
  • Ileana Nicoleta Popescu,
  • Olfa Kamoun,
  • Feras Alzubi,
  • Sami Alawadhia and
  • Ruxandra Vidu

18 November 2020

The coronavirus disease 2019 (COVID-19) pandemic is considered a public health emergency of international concern. The 2019 novel coronavirus (2019-nCoV) or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that caused this pandemic has sp...

  • Review
  • Open Access
33 Citations
6,872 Views
23 Pages

SARS-CoV-2 and Viral Sepsis: Immune Dysfunction and Implications in Kidney Failure

  • Alessandra Stasi,
  • Giuseppe Castellano,
  • Elena Ranieri,
  • Barbara Infante,
  • Giovanni Stallone,
  • Loreto Gesualdo and
  • Giuseppe Stefano Netti

15 December 2020

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causal agent of coronavirus disease 2019 (COVID-19), first emerged in Wuhan, China. The clinical manifestations of patients infected with COVID-19 include fever, cough, and dyspnea, up...

  • Review
  • Open Access
52 Citations
15,270 Views
9 Pages

COVID-19 Drug Discovery Using Intensive Approaches

  • Ayumu Asai,
  • Masamitsu Konno,
  • Miyuki Ozaki,
  • Chihiro Otsuka,
  • Andrea Vecchione,
  • Takahiro Arai,
  • Toru Kitagawa,
  • Ken Ofusa,
  • Masami Yabumoto and
  • Hideshi Ishii
  • + 4 authors

Since the infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported in China during December 2019, the coronavirus disease 2019 (COVID-19) has spread on a global scale, causing the World Health Organizatio...

  • Review
  • Open Access
2 Citations
4,452 Views
6 Pages

NeuroCOVID: Insights into Neuroinvasion and Pathophysiology

  • Jakob Matschke,
  • Susanne Krasemann,
  • Hermann C. Altmeppen,
  • Mohsin Shafiq and
  • Markus Glatzel

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), may lead to acute and chronic neurological symptoms (NeuroCOVID-19). SARS-CoV-2 may spread from the respiratory tract to the central nervous...

  • Review
  • Open Access
2 Citations
2,705 Views
12 Pages

The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), appears to be diminishing in infectivity and hospitalizations in the United States and many parts of the world. This review will...

  • Review
  • Open Access
14 Citations
4,185 Views
16 Pages

Redox Homeostasis and Immune Alterations in Coronavirus Disease-19

  • Francesco Bellanti,
  • Aurelio Lo Buglio and
  • Gianluigi Vendemiale

19 January 2022

The global Coronavirus Disease 2019 (COVID-19) pandemic is characterized by a wide variety of clinical features, from no or moderate symptoms to severe illness. COVID-19 is caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) th...

  • Opinion
  • Open Access
18 Citations
5,988 Views
14 Pages

Cancer Patients Have a Higher Risk Regarding COVID-19–and Vice Versa?

  • Franz Geisslinger,
  • Angelika M. Vollmar and
  • Karin Bartel

The world is currently suffering from a pandemic which has claimed the lives of over 230,000 people to date. The responsible virus is called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and causes the coronavirus disease 2019 (COVID-1...

  • Review
  • Open Access
21 Citations
6,017 Views
28 Pages

Anticoronavirus and Immunomodulatory Phenolic Compounds: Opportunities and Pharmacotherapeutic Perspectives

  • Naiara Naiana Dejani,
  • Hatem A. Elshabrawy,
  • Carlos da Silva Maia Bezerra Filho and
  • Damião Pergentino de Sousa

23 August 2021

In 2019, COVID-19 emerged as a severe respiratory disease that is caused by the novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The disease has been associated with high mortality rate, especially in patients with com...

  • Article
  • Open Access
9 Citations
6,321 Views
17 Pages

Proteomic Analysis Identifies Molecular Players and Biological Processes Specific to SARS-CoV-2 Exposure in Endothelial Cells

  • Thatiana Corrêa de Melo,
  • Dilza Trevisan-Silva,
  • Miryam P. Alvarez-Flores,
  • Renata Nascimento Gomes,
  • Marcelo Medina de Souza,
  • Hellen Paula Valerio,
  • Douglas S. Oliveira,
  • Carlos DeOcesano-Pereira,
  • Viviane Fongaro Botosso and
  • Ana Marisa Chudzinski-Tavassi
  • + 3 authors

9 September 2022

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been responsible for the severe pandemic of acute respiratory disease, coronavirus disease 2019 (COVID-19), experienced in the 21st century. The clinical manifestations range from mild...

  • Review
  • Open Access
10 Citations
2,949 Views
11 Pages

11 November 2021

Crohn’s disease and ulcerative colitis are chronic inflammatory bowel diseases (IBDs). Immunosuppressive medication is the main therapeutic approach to reducing inflammation of the gastrointestinal tract. Immunocompromised patients are more vulnerabl...

  • Editorial
  • Open Access
4 Citations
4,380 Views
5 Pages

28 December 2021

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogen responsible for the coronavirus disease 2019 (COVID-19) and the ongoing worldwide pandemic, has cost the lives of almost 5 [...]

  • Editorial
  • Open Access
16 Citations
5,104 Views
2 Pages

11 February 2021

The latest chapter of the historic battle of humans against pathogenic microbes is the severe acute respiratory syndrome (SARS)-like coronavirus-2 (SARS-CoV-2), responsible for COVID-19, a respiratory disease declared a global pandemic by the WHO on...

  • Review
  • Open Access
38 Citations
6,046 Views
20 Pages

14 December 2022

Viruses, including influenza viruses, MERS-CoV (Middle East respiratory syndrome coronavirus), SARS-CoV (severe acute respiratory syndrome coronavirus), HAV (Hepatitis A virus), HBV (Hepatitis B virus), HCV (Hepatitis C virus), HIV (human immunodefic...

  • Article
  • Open Access
12 Citations
4,707 Views
17 Pages

Characterization of the SARS-CoV-2 Host Response in Primary Human Airway Epithelial Cells from Aged Individuals

  • Bharathiraja Subramaniyan,
  • Jason L. Larabee,
  • Manish Bodas,
  • Andrew R. Moore,
  • Anthony W. G. Burgett,
  • Dean A. Myers,
  • Constantin Georgescu,
  • Jonathan D. Wren,
  • James F. Papin and
  • Matthew S. Walters

12 August 2021

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19), a global pandemic characterized by an exaggerated immune response and respiratory illness. Age (>60 years) is a significant...

  • Editorial
  • Open Access
24 Citations
5,653 Views
2 Pages

The “Severe Acute Respiratory Syndrome Coronavirus Type 2” (SARS-CoV-2) has been identified as the infectious agent responsible for the generally mild but sometimes life-threatening communicable disease known as “Coronavirus Disease...

  • Editorial
  • Open Access
3 Citations
5,757 Views
7 Pages

SARS-CoV-2 Induced Herpes Virus Reactivations and Related Implications in Oncohematology: When Lymphocytopenia Sets in and Immunosurveillance Drops Out

  • Luca Roncati,
  • Elizabeth Sweidan,
  • Cyrielle Tchawa,
  • Greta Gianotti,
  • Gianluca Di Massa,
  • Flavia Siciliano and
  • Ambra Paolini

The severe acute respiratory syndrome, coronavirus 2 (SARS-CoV-2), is a positive-sense single-stranded ribonucleic acid (RNA) virus contagious in humans and responsible for the ongoing coronavirus disease 2019 (COVID-19) [...]

  • Editorial
  • Open Access
1 Citations
1,540 Views
3 Pages

26 February 2023

Three years after coronavirus disease 2019 (COVID-19) was declared a pandemic by the World Health Organization (WHO), several features of the pathogenesis and innate immune response to SARS-CoV-2 (severe acute respiratory syndrome coronavirus disease...

  • Editorial
  • Open Access
3 Citations
1,616 Views
4 Pages

13 May 2023

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for coronavirus disease 2019 (COVID-19), has caused severe illness and mortality on a global scale, with an impact not witnessed since the 1918–19 Spanish influ...

  • Review
  • Open Access
6 Citations
3,570 Views
11 Pages

Current SARS-CoV-2 Protective Strategies for Healthcare Professionals

  • Miriam Ting,
  • John A. Molinari and
  • Jon B. Suzuki

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for the Coronavirus disease 2019 (COVID-19). COVID-19 was first reported in China in December 2019. SARS-CoV-2 is highly contagious and spread primarily via an airborne route...

  • Review
  • Open Access
26 Citations
9,816 Views
24 Pages

SARS–CoV-2 Immuno-Pathogenesis and Potential for Diverse Vaccines and Therapies: Opportunities and Challenges

  • Andrew R. McGill,
  • Roukiah Khalil,
  • Rinku Dutta,
  • Ryan Green,
  • Mark Howell,
  • Subhra Mohapatra and
  • Shyam S. Mohapatra

4 February 2021

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a novel coronavirus that emerged from Wuhan, China in late 2019 causing coronavirus disease-19 (COVID-19). SARS-CoV-2 infection begins by attaching to angiotensin-converting enzyme 2 rec...

  • Article
  • Open Access
4 Citations
5,768 Views
16 Pages

Increased COVID-19 Mortality and Deficient SARS-CoV-2 Immune Response Are Not Associated with Higher Levels of Endemic Coronavirus Antibodies

  • Bindu Adhikari,
  • Eugene M. Oltz,
  • Joseph S. Bednash,
  • Jeffrey C. Horowitz,
  • Joshua O. Amimo,
  • Sergei A. Raev,
  • Soledad Fernández,
  • Mirela Anghelina,
  • Shan-Lu Liu and
  • Anastasia N. Vlasova
  • + 3 authors

4 September 2023

The impact of pre-existing common cold coronavirus (CCCoV) antibodies (Abs) on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immune responses and pathogenesis remains poorly defined. We evaluated these associations in a cohort of hospi...

  • Review
  • Open Access
3 Citations
8,638 Views
13 Pages

5 January 2022

Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a pandemic and caused a huge burden to healthcare systems worldwide. One of the characteristic symptoms of COVID-19 is asymptomatic hyp...

  • Review
  • Open Access
7 Citations
6,618 Views
14 Pages

Mast Cell Tryptase and Implications for SARS-CoV-2 Pathogenesis

  • Negar Karimi,
  • Solmaz Morovati,
  • Lily Chan,
  • Christina Napoleoni,
  • Yeganeh Mehrani,
  • Byram W. Bridle and
  • Khalil Karimi

17 December 2021

Mast cells (MCs) are heterogenous innate leukocytes producing many inflammatory mediators during viral infections that can be protective or damaging to the host, as is seen in the infection with the severe acute respiratory syndrome coronavirus 2 (SA...

  • Editorial
  • Open Access
2 Citations
1,617 Views
3 Pages

8 November 2023

The aim of this Special Issue is to analyze the key patterns of the 2019 coronavirus disease pandemic (COVID-19), the biology of SARS-CoV-2 (severe-acute-respiratory-syndrome-related coronavirus 2, formerly 2019-nCoV), and the characteristics of the...

  • Article
  • Open Access
10 Citations
3,453 Views
25 Pages

The Stereotypic Response of the Pulmonary Vasculature to Respiratory Viral Infections: Findings in Mouse Models of SARS-CoV-2, Influenza A and Gammaherpesvirus Infections

  • Simon De Neck,
  • Rebekah Penrice-Randal,
  • Jordan J. Clark,
  • Parul Sharma,
  • Eleanor G. Bentley,
  • Adam Kirby,
  • Daniele F. Mega,
  • Ximeng Han,
  • Andrew Owen and
  • Anja Kipar
  • + 2 authors

27 July 2023

The respiratory system is the main target of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 19 (COVID-19) where acute respiratory distress syndrome is considered the leading cause of death. Changes in p...

  • Review
  • Open Access
28 Citations
7,119 Views
16 Pages

Comorbidities of COVID-19 Patients

  • Radu Silaghi-Dumitrescu,
  • Iulia Patrascu,
  • Maria Lehene and
  • Iulia Bercea

29 July 2023

The novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) responsible for the coronavirus disease outbreak initiated in 2019 (COVID-19) has been shown to affect the health of infected patients in a manner at times dependent on pre-existi...

  • Review
  • Open Access
27 Citations
7,126 Views
23 Pages

The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis

  • Angela Dziedzic,
  • Joanna Saluk-Bijak,
  • Elzbieta Miller,
  • Marcin Niemcewicz and
  • Michal Bijak

11 February 2021

The novel coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains a global challenge. Currently, there is some information on the consequences of COVID-19 infection in multiple scl...

  • Review
  • Open Access
131 Citations
13,876 Views
28 Pages

Interactions of SARS-CoV-2 with the Blood–Brain Barrier

  • Michelle A. Erickson,
  • Elizabeth M. Rhea,
  • Rachel C. Knopp and
  • William A. Banks

Emerging data indicate that neurological complications occur as a consequence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The blood–brain barrier (BBB) is a critical interface that regulates entry of circulating molecul...

  • Review
  • Open Access
63 Citations
8,988 Views
14 Pages

16 August 2021

The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the causative agent of the ongoing pandemic of coronavirus disease 2019 (COVID-19). The clinical severity of COVID-19 ranges from asymptomatic to critical disease...

  • Article
  • Open Access
8 Citations
2,837 Views
15 Pages

Elevated SARS-CoV-2-Specific Antibody Levels in Patients with Post-COVID Syndrome

  • Christopher Hackenbruch,
  • Yacine Maringer,
  • Christian M. Tegeler,
  • Juliane S. Walz,
  • Annika Nelde and
  • Jonas S. Heitmann

8 March 2023

With the routine use of effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines, the number of life-threatening coronavirus disease 2019 (COVID-19) courses have largely been reduced. However, multiple COVID-19 convalescents, e...

  • Review
  • Open Access
63 Citations
6,960 Views
16 Pages

Inflammatory Mechanisms in COVID-19 and Atherosclerosis: Current Pharmaceutical Perspectives

  • Marios Sagris,
  • Panagiotis Theofilis,
  • Alexios S. Antonopoulos,
  • Costas Tsioufis,
  • Evangelos Oikonomou,
  • Charalambos Antoniades,
  • Filippo Crea,
  • Juan Carlos Kaski and
  • Dimitris Tousoulis

Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been associated with excess mortality worldwide. The cardiovascular system is the second most common target of SARS-CoV-2, which leads...

  • Case Report
  • Open Access
8 Citations
2,464 Views
9 Pages

Severe COVID-19 Complicated by Cerebral Venous Thrombosis in a Newborn Successfully Treated with Remdesivir, Glucocorticoids, and Hyperimmune Plasma

  • Laura Cursi,
  • Francesca Ippolita Calo Carducci,
  • Sara Chiurchiu,
  • Lorenza Romani,
  • Francesca Stoppa,
  • Giulia Lucignani,
  • Cristina Russo,
  • Daniela Longo,
  • Carlo Federico Perno and
  • Paolo Rossi
  • + 5 authors

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for the coronavirus disease 2019 (COVID-19) pandemic, affecting all age groups with a wide spectrum of clinical presentation ranging from asymptomatic to severe interstitial...

  • Review
  • Open Access
30 Citations
6,406 Views
14 Pages

COVID-19 and Neurological Impairment: Hypothalamic Circuits and Beyond

  • Bashair M. Mussa,
  • Ankita Srivastava and
  • Anthony J. M. Verberne

17 March 2021

In December 2019, a novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, the capital of Hubei, China. The virus infection, coronavirus disease 2019 (COVID-19), represents a global concern, as almos...

  • Review
  • Open Access
12 Citations
4,033 Views
14 Pages

6 July 2021

The link between severe forms of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and cardiovascular diseases has been well documented by various studies that indicated a higher risk of cardiovascular complications in COVID-19 p...

  • Review
  • Open Access
34 Citations
5,822 Views
25 Pages

8 November 2021

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global pandemic with a great impact on social and economic activities, as well as public health. In most patients, the symptoms...

  • Article
  • Open Access
5 Citations
4,584 Views
10 Pages

Longitudinal Analysis of Coronavirus-Neutralizing Activity in COVID-19 Patients

  • Florian D. Hastert,
  • Lisa Henss,
  • Christine von Rhein,
  • Julia Gerbeth,
  • Imke Wieters,
  • Frauke Borgans,
  • Yascha Khodamoradi,
  • Kai Zacharowski,
  • Gernot Rohde and
  • Barbara S. Schnierle
  • + 1 author

23 April 2022

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic has now been continuing for more than two years. The infection causes COVID-19, a disease of the respiratory and cardiovascular system of variable severity. Here, the humoral i...

  • Article
  • Open Access
1 Citations
1,985 Views
13 Pages

Immune Profile in COVID-19: Unveiling TR3-56 Cells in SARS-CoV-2 Infection

  • Flavia Carriero,
  • Valentina Rubino,
  • Monica Gelzo,
  • Giulia Scalia,
  • Maddalena Raia,
  • Massimo Ciccozzi,
  • Ivan Gentile,
  • Biagio Pinchera,
  • Giuseppe Castaldo and
  • Giuseppe Terrazzano
  • + 1 author

28 September 2024

The emergence of COronaVIrus Disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), presented a global health challenge since its identification in December 2019. With clinical manifestations ranging from mil...

  • Article
  • Open Access
102 Citations
9,257 Views
18 Pages

The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner

  • Victoria Callahan,
  • Seth Hawks,
  • Matthew A. Crawford,
  • Caitlin W. Lehman,
  • Holly A. Morrison,
  • Hannah M. Ivester,
  • Ivan Akhrymuk,
  • Niloufar Boghdeh,
  • Rafaela Flor and
  • Kylene Kehn-Hall
  • + 5 authors

3 June 2021

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible RNA virus that is the causative agent of the Coronavirus disease 2019 (COVID-19) pandemic. Patients with severe COVID-19 may develop acute lung injury (ALI) or acu...

  • Review
  • Open Access
37 Citations
5,445 Views
11 Pages

22 October 2021

The global coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection, threatens the entire world. It has affected every aspect of life and increased the burden on both healthcare an...

  • Review
  • Open Access
56 Citations
8,078 Views
14 Pages

Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review

  • Aneta Aleksova,
  • Giulia Gagno,
  • Gianfranco Sinagra,
  • Antonio Paolo Beltrami,
  • Milijana Janjusevic,
  • Giuseppe Ippolito,
  • Alimuddin Zumla,
  • Alessandra Lucia Fluca and
  • Federico Ferro

Angiotensin-converting enzyme 2 (ACE2) is the entry receptor for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the cause of Coronavirus Disease-2019 (COVID-19) in humans. ACE-2 is a type I transmembrane metallocarboxypeptidase express...

  • Review
  • Open Access
24 Citations
6,955 Views
15 Pages

Pulmonary Delivery of Fenretinide: A Possible Adjuvant Treatment in COVID-19

  • Isabella Orienti,
  • Giovanna Angela Gentilomi and
  • Giovanna Farruggia

At present, there is no vaccine or effective standard treatment for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection (or coronavirus disease-19 (COVID-19)), which frequently leads to lethal pulmonary inflammatory responses. COVI...

  • Review
  • Open Access
53 Citations
7,228 Views
15 Pages

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel human coronavirus, emerged in late 2019 and rapidly evolved into a pandemic around the world. The coronavirus disease (COVID-19) pandemic has dramatically changed the epidemiology...

  • Review
  • Open Access
20 Citations
9,545 Views
19 Pages

18 November 2022

Coronavirus disease 2019 (COVID-19) is an infectious viral disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). It is known that infection with SARS-CoV-2 can lead to various autoimmune and autoinflammatory diseases. There...

  • Review
  • Open Access
5 Citations
3,350 Views
14 Pages

Development of Single-Cell Transcriptomics and Its Application in COVID-19

  • Chaochao Wang,
  • Ting Huyan,
  • Xiaojie Zhou,
  • Xuanshuo Zhang,
  • Suyang Duan,
  • Shan Gao,
  • Shanfeng Jiang and
  • Qi Li

16 October 2022

Over the last three years, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related health crisis has claimed over six million lives and caused USD 12 trillion losses to the global economy. SARS-CoV-2 continuously mutates and evolves...

  • Article
  • Open Access
5 Citations
3,530 Views
17 Pages

Plasma Proteomics Elucidated a Protein Signature in COVID-19 Patients with Comorbidities and Early-Diagnosis Biomarkers

  • Víctor Urbiola-Salvador,
  • Suiane Lima de Souza,
  • Katarzyna Macur,
  • Paulina Czaplewska and
  • Zhi Chen

Despite great scientific efforts, deep understanding of coronavirus-19 disease (COVID-19) immunopathology and clinical biomarkers remains a challenge. Pre-existing comorbidities increase the mortality rate and aggravate the exacerbated immune respons...

  • Review
  • Open Access
8 Citations
6,413 Views
34 Pages

Implications of the Immune Polymorphisms of the Host and the Genetic Variability of SARS-CoV-2 in the Development of COVID-19

  • Jesús Zepeda-Cervantes,
  • Daniel Martínez-Flores,
  • Josué Orlando Ramírez-Jarquín,
  • Ángeles C. Tecalco-Cruz,
  • Noé Santiago Alavez-Pérez,
  • Luis Vaca and
  • Rosa Elena Sarmiento-Silva

6 January 2022

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for the current pandemic affecting almost all countries in the world. SARS-CoV-2 is the agent responsible for coronavirus disease 19 (COVID-19), which has claimed million...

  • Review
  • Open Access
26 Citations
8,973 Views
29 Pages

COVID-19 Research: Lessons from Non-Human Primate Models

  • Laure Albrecht,
  • Elodie Bishop,
  • Basile Jay,
  • Blaise Lafoux,
  • Marie Minoves and
  • Caroline Passaes

10 August 2021

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease 2019 (COVID-19). It emerged from China in December 2019 and rapidly spread across the globe, causing a pandemic with unprecedented impacts on publ...

of 13